Thermo Fisher Scientific (TMO)
NYSE • Healthcare
May 20, 2026 at 16:00 UTC
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is a life-science tools and services company that helps laboratories, manufacturers, and health systems turn experiments into routine outcomes. It supplies technology and know-how for sample preparation, measurement, and regulated production, with delivery models that range from instruments on site to outsourced scientific services. The approach is practical: keep methods consistent, documentation clear, and supply reliable so work can move from discovery to everyday use without constant reinvention. Teams support customers in research, diagnostics, and bioproduction, aligning procedures with standards that travel across regions. By pairing science with service, the company positions itself as infrastructure for modern laboratories and plants rather than a single product bet, aiming to make complex workflows feel predictable in real settings.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Thermo Fisher Scientific's Technical Indicators Summary
TMO displays a bearish technical profile with price well below its short-, medium- and long-term moving averages and MACD deeply negative, signaling persistent selling. ADX above 30 indicates the downtrend has strength, while momentum measures are weak and OBV shows distribution despite a positive nominal value. Volatility is moderate as ATR is elevated but not extreme, and pivot levels are near the current trading zone. Technical takeaway: Bearish — strong trend and negative momentum favor continued downside pressure within orderly volatility.
| Indicator | Value |
|---|---|
RSI (14) | 35.41 |
Stochastic %K (14, 3, 3) | 8.88 |
CCI (20) | -146.27 |
WPR (14) | -85.55 |
Momentum (10) | -20.60 |
MFI | 40.87 |
MACD Level (12, 26) | -13.77 |
Bollinger Bands | $426.00 - $509.59 |
ATR (14) | $14.47 (3.27%) |
ADX (14) | 30.78 |
OBV | 15,524,965 |
Classic Pivot Point | $440.20 |
Fibonacci Pivot Point | $440.20 |
Simple Moving Averages | $456.56 - $526.87(5 indicators) |
Exponential Moving Averages | $454.17 - $504.51(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Into the close, TMO retained a slight positive bias, with the 0.85% gap from yesterday leaving it near 451.62. The day closed with TMO's options tilted bullish, as the put/call ratio settled around 0.62. TMO trades higher on Investor Day showing AI-driven growth and strong leadership, boosting its near-term outlook.
Price Change
from $449.96 close
+$1.63
Trading Volume
Below avg (2.8M)
2.4M
vs S&P 500 Today
Outperforming Market
+2.76%
52-Week Position
Lower range
25.6%
Updated: May 20, 2026 at 20:14 UTC
Quote Summary
TMO Headlines
Q1 2026 Earnings Roundup: Utilities and Tools
April 23, 2026
Thermo Fisher prices $3.8B notes for Clario deal
February 10, 2026
AI boom powers chips, storage, and lab-tech deals
January 18, 2026